Sunshine Biopharma Inc. (SBFM)
NASDAQ · Healthcare
Sunshine Biopharma Inc. Gross Profit 2017–2025
Sunshine Biopharma Inc. annual/quarterly gross profit history and growth rate from 2017 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Sunshine Biopharma Inc. gross profit for the quarter ending March 31, 2026 was 2.2 M, a 20.12% decrease year-over-year.
- Sunshine Biopharma Inc. gross profit for the twelve months ending March 31, 2026 was 11.4 M, a 19.24% increase year-over-year.
- Sunshine Biopharma Inc. annual gross profit for 2025 was 12.3 M, a 14.86% increase from 2024.
- Sunshine Biopharma Inc. annual gross profit for 2024 was 10.7 M, a 27.95% increase from 2023.
- Sunshine Biopharma Inc. annual gross profit for 2023 was 8.3 M, a 391.53% increase from 2022.
- Sunshine Biopharma Inc. annual gross profit for 2022 was 1.7 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Sunshine Biopharma Inc. Gross Profit — FAQ
Sunshine Biopharma Inc. (SBFM) gross profit over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Sunshine Biopharma Inc.'s gross profit?
Sunshine Biopharma Inc. (SBFM) reported gross profit of $12M for fiscal 2025.
Where can I see SBFM's gross profit history?
The chart and table above show Sunshine Biopharma Inc.'s gross profit by year and by quarter, including the growth rate.